Moved by
Lord Lansley
10: After Clause 3, insert the following new Clause—
“Price control: criteria
After section 264 of the National Health Service Act 2006 (statutory schemes: supplementary) insert—
“264ZZA Price control: criteria
(1) In determining the prices of medicines under sections 261 and 263 of this Act, the Secretary of State must have regard to the criteria listed in subsection (2), insofar as the prices concerned relate to a new chemical entity, or a new indication for the use of an existing medicine.
(2) The criteria are—
(a) the prospective therapeutic benefit to patients;
(b) the extent to which the therapy meets an as yet unmet need;
(c) any wider social benefits which would accrue from the medicine’s use;
(d) the desirability of making licensed medicines available to clinicians and their patients, for use where they are the most clinically appropriate treatment;
(e) the desirability of promoting innovation in new therapies; and
(f) affordability for the National Health Service, including any evaluation of the relative benefit of the medicine compared to other treatments available.””